Back to trial detailsIntake questionnaire
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Applying to Providence Medical Foundation (site 209) · Santa Rosa, California
Answer a few short questions to share with the research team.
0 of 3 answered